The Effect of Acupuncture Treatment for Patients with Atopic Dermatitis Accompanied by Bowel Symptoms

The Effect of Acupuncture Treatment for Patients with Atopic Dermatitis Accompanied by Bowel Symptoms: A Multicenter, Assessor-blinded, Randomized Controlled Trial

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0010770

Enrollment

Registered

2025-07-16

Start date

2025-03-27

Completion date

Unknown

Last updated

2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device, Others : ¦ Verum Acupuncture Group The verum acupuncture group receives real needle insertion combined with low-frequency electroacupuncture. Bilateral LI11 (Large Intestine 11) and ST

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion Criteria 1) Male or female adults aged between 19 and 65 years. 2) Individuals diagnosed with atopic dermatitis based on the Hanifin and Rajka criteria, meeting at least 3 major and 4 minor criteria. 3) Individuals diagnosed with a functional bowel disorder according to the Rome IV Questionnaire. 4) Individuals with a SCORAD (Scoring Atopic Dermatitis) score between 15 and 50, corresponding to mild to moderate severity. 5) Individuals who have received sufficient explanation about the purpose and details of the study, voluntarily agreed to participate, and signed the informed consent form.

Exclusion criteria

Exclusion criteria: Exclusion Criteria 1) Individuals who have used oral corticosteroids, antibiotics, systemic photochemotherapy, or immunomodulatory agents, or who have received Korean medical treatments such as herbal medicine, acupuncture, or moxibustion within 4 weeks prior to screening. 2) Individuals who have taken probiotic supplements within 1 week before screening. 3) Pregnant or breastfeeding women, or women planning to become pregnant. 4) Individuals with communication difficulties who are deemed unable to follow the investigator’s instructions. 5) Individuals who are currently participating in another interventional clinical trial or who plan to participate in another trial during the study period. 6) Individuals deemed unsuitable for participation by the investigator for any other reason.

Design outcomes

Primary

Measure	Time frame
Scoring Atopic Dermatitis(SCORAD) Index	—

Secondary

Measure	Time frame
Itch Visual Analog Scale (Itch VAS);Eczema Area Severity Index(EASI);Dermatology Life Quality Index(DLQI);Gastrointestinal Symptom Rating Scale (GSRS);Exploratory analysis of immune/inflammatory biomarkers in blood;Changes in gut microbiota	—

Countries

Korea, Republic of

Contacts

Public ContactSoojin Park

Kyung Hee University Industry-University Cooperation Foundation

sj427@naver.com+82-2-958-9181

Outcome results